GLPBio

EX229

Catalog No.: GC31411Purity:>98.00%Synonyms: AMPK Activator 991
EX229 ، أحد مشتقات بنزيميدازول ، هو منشط قوي وخيفي لبروتين كيناز منشط AMP (AMPK) ، مع Kds من 0.06 ميكرومتر و 0.06 ميكرومتر و 0.51 ميكرومتر لـ α1β1γ1 و α2β1γ1 و α1β2γ1 في قياس التداخل ثنائي الطبقة ، على التوالي

المنتجات مخصصة للاستخدام البحثي فقط، وليست للاستخدام البشري. نحن لا نبيع للمرضى.


EX229
Cas No.: 1219739-36-2
10mM (in 1mL DMSO)In Stock
$85.00
1
1mgIn Stock
$24.00
1
5mgIn Stock
$69.00
1
10mgIn Stock
$115.00
1
25mgIn Stock
$207.00
1
50mgIn Stock
$308.00
1

المراجع (Citations)

لا تتوفر حاليًا مراجع لهذا المنتج. فيما يلي مجموعة مختارة من المنشورات التي تستشهد بمنتجات GlpBio.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

الوصف (Description)

EX229 is a benzimidazole derivative that functions as a potent allosteric agonist of AMP-activated protein kinase (AMPK)[1]. EX229 binds to AMPK with high specificity, exhibiting differential binding affinity for various isoforms: α1β1γ1 (Kd=0.06μM), α2β1γ1 (Kd=0.06μM), and α1β2γ1 (Kd=0.51μM)[2]. EX229 effectively regulates glucose transport and inhibits lipogenesis[3].

In vitro, treatment of C2C12 myotube cells with EX229 (2–25μM) for 12 hours significantly activated the AMPK signaling pathway, as indicated by a dose-dependent increase in AMPKα phosphorylation. This was accompanied by upregulation of key unfolded protein response (UPR) markers, including ATF4 and CHOP, at the protein level[4].

In vivo, daily intramuscular administration of EX229 (2.0mg/kg) for 8 weeks in a rat model of heart failure induced by coronary artery ligation significantly reversed the cardioprotective effects of Fuyu Decoction. This was demonstrated by a marked increase in left ventricular end-diastolic volume (LVEDV) and end-systolic volume (LVESV), along with a significant reduction in left ventricular ejection fraction (LVEF) and fractional shortening (LVFS)[5].

References:
[1] Lai YC, Kviklyte S, Vertommen D, et al. A small-molecule benzimidazole derivative that potently activates AMPK to increase glucose transport in skeletal muscle: comparison with effects of contraction and other AMPK activators. Biochem J. 2014 Jun 15;460(3):363-75.
[2] Xiao B, Sanders MJ, Carmena D, et al. Structural basis of AMPK regulation by small molecule activators. Nat Commun. 2013;4:3017.
[3] Bultot L, Jensen TE, Lai YC, et al. Benzimidazole derivative small-molecule 991 enhances AMPK activity and glucose uptake induced by AICAR or contraction in skeletal muscle. Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E706-E719.
[4] Gong J, Wang L, Tao W, et al. AMPK Mediates Early Activation of the Unfolded Protein Response through a Positive Feedback Loop in Palmitate-Treated Muscle Cells. Front Biosci (Landmark Ed). 2023 Aug 7;28(8):159.
[5] Ma J, Xu Z, Zhu J, et al. Fuyu Decoction improves ventricular remodeling in rats with heart failure by inhibiting AMPK/mTOR pathway-mediated autophagy. Nan Fang Yi Ke Da Xue Xue Bao. 2023 Mar 20;43(3):466-473. 

البروتوكول (Protocol)

Cell experiment [1]:

Cell lines

C2C12 myotubes (mouse skeletal muscle cell line)

Preparation Method

C2C12 myoblasts were differentiated into myotubes in high-glucose DMEM supplemented with 2% horse serum for 4 days. Myotubes were treated with EX229 at concentrations ranging from 2 to 25μM for 12 hours.

Reaction Conditions

2-25μM; 12 hours

Applications

EX229 dose-dependently activated AMPK signaling, as evidenced by increased phosphorylation of AMPKα (p-AMPKα). This activation subsequently induced the unfolded protein response (UPR), marked by upregulated protein expression of UPR markers ATF4 and CHOP. EX229 also enhanced the mRNA levels of UPR-related genes, including BIP, ATF4, GADD34, and XBP1s, demonstrating EX229 role in promoting ER stress adaptation.

Animal experiment [2]:

Animal models

Male Wistar rats with heart failure induced by ligation of the left anterior descending coronary artery

Preparation Method

Rats were treated with EX229 (2.0mg/kg) via daily intramuscular injection for 8 weeks, starting 4 weeks after heart failure induction. The treatment was combined with Fuyu Decoction (5.0g/kg, oral gavage) in the Fuyu Soup+EX229 group.

Dosage form

2.0mg/kg; i.m.

Applications

EX229 administration significantly reversed the cardioprotective effects of Fuyu Decoction, exacerbating heart failure progression. EX229 increased left ventricular end-diastolic volume (LVEDV) and end-systolic volume (LVESV), reduced ejection fraction (LVEF) and fractional shortening (LVFS), and worsened ventricular remodeling indicators. EX229 also amplified myocardial infarction area, promoted cardiomyocyte apoptosis, and enhanced autophagy activation via the AMPK/mTOR pathway, as evidenced by upregulated p-AMPK, LC3-II/LC3-I, and Beclin1 expressions, and suppressed p-mTOR and p62 levels.

References:
[1] Gong J, Wang L, Tao W, et al. AMPK Mediates Early Activation of the Unfolded Protein Response through a Positive Feedback Loop in Palmitate-Treated Muscle Cells. Front Biosci (Landmark Ed). 2023 Aug 7;28(8):159.
[2] Ma J, Xu Z, Zhu J, et al. Fuyu Decoction improves ventricular remodeling in rats with heart failure by inhibiting AMPK/mTOR pathway-mediated autophagy. Nan Fang Yi Ke Da Xue Xue Bao. 2023 Mar 20;43(3):466-473. 

وثائق المنتج (Product Documents)

Purity:>98.00%Appearance:A solid

الخصائص الكيميائية (Chemical Properties)

رقم CAS
1219739-36-2
المرادفات
AMPK Activator 991
SMILES
O=C(O)C1=CC(OC2=NC3=CC(Cl)=C(C4=CC5=C(N(C)C=C5)C=C4)C=C3N2)=CC=C1C
الصيغة الجزيئية
C24H18ClN3O3
الوزن الجزيئي
431.87
الذوبانية
DMSO : 5.4 mg/mL (12.50 mM)
التخزين
Store at -20°C
إرشادات عامة
اختر مذيبًا مناسبًا وفقًا لبيانات ذوبانية المنتج. بعد التحضير، قسّم المحلول المخزون إلى أجزاء لتجنب دورات التجميد والذوبان المتكررة.
استخدم المحاليل المخزونة خلال 6 أشهر عند حفظها في -80°C، أو خلال شهر واحد عند حفظها في -20°C.
لتحسين الذوبانية، سخّن الأنبوب إلى 37°C وعرّضه للموجات فوق الصوتية لمدة مناسبة.
شروط الشحن
تُشحن عينات التقييم مع عبوات تبريد. وتُشحن الأحجام الأخرى المتاحة في درجة حرارة الغرفة، أو مع عبوات تبريد عند الطلب.

الحاسبات (Calculators)المولارية / التخفيف / الوزن الجزيئي / تحويل الوحدات / تركيبة داخل الجسم الحي / الذوبانية

g/mol

Reviews

Review for EX229

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%